Key Points Interested in Astrazeneca Plc? Here are five stocks we like better. AstraZeneca updated its 2030 sustainability ...

Shares of AstraZeneca PLC AZN rose 1.63% to £125.66 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.13% to 10,515.92.

UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has agreed to pay $600 million upfront to secure worldwide rights to a lung cancer pill ...

Sino Biopharmaceutical Limited expanded its strategic partnership with GSK Plc GSK and separately signed an exclusive ...

AstraZeneca PLC on Tuesday said it has entered into a deal to license a lung cancer therapy, in a deal worth up to USD1.5 ...

Good afternoon, and welcome to AstraZeneca's H1 and Q2 2025 webinar for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to ...

EsoBiotec SA, a biotechnology company specializing in in vivo cell therapies, has announced a definitive agreement to be acquired by AstraZeneca PLC (NYSE:AZN). The agreement represents a major step ...

AstraZeneca PLC AZN shares slid 3.89% to £128.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.24% to 10,497.29.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action ...

Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NYSE: AZN). Such investors are advised ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...